MASOLA, Valentina
 Distribuzione geografica
Continente #
EU - Europa 1.898
NA - Nord America 1.625
AS - Asia 1.081
SA - Sud America 165
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.791
Nazione #
US - Stati Uniti d'America 1.599
RU - Federazione Russa 771
SG - Singapore 454
GB - Regno Unito 401
CN - Cina 358
IT - Italia 170
BR - Brasile 128
SE - Svezia 127
FR - Francia 110
HK - Hong Kong 88
IE - Irlanda 86
VN - Vietnam 86
FI - Finlandia 81
DE - Germania 78
UA - Ucraina 23
AR - Argentina 20
ID - Indonesia 17
BE - Belgio 13
IN - India 11
AT - Austria 10
KR - Corea 10
BD - Bangladesh 9
MX - Messico 9
CA - Canada 8
IL - Israele 7
ZA - Sudafrica 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CO - Colombia 4
EC - Ecuador 4
ES - Italia 4
JP - Giappone 4
MA - Marocco 4
PL - Polonia 4
TR - Turchia 4
VE - Venezuela 4
CL - Cile 3
IQ - Iraq 3
LB - Libano 3
PK - Pakistan 3
PS - Palestinian Territory 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
KG - Kirghizistan 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.791
Città #
Southend 355
Moscow 274
Chandler 271
Singapore 205
Jacksonville 136
Woodbridge 130
Ashburn 107
Dallas 107
Ann Arbor 96
Hong Kong 87
Dublin 84
Beijing 78
Houston 47
Wilmington 40
Lawrence 37
Princeton 37
The Dalles 37
New York 35
Los Angeles 25
Nanjing 22
Redondo Beach 21
Columbus 20
Dong Ket 20
Shenyang 20
Jinan 19
Helsinki 18
Ho Chi Minh City 18
Redmond 17
Verona 17
São Paulo 15
Buffalo 14
Munich 14
Brussels 13
Tianjin 13
Council Bluffs 12
Jakarta 11
Seattle 11
Hebei 10
Milan 10
Santa Clara 10
Vienna 10
Boardman 9
Hanoi 9
Taizhou 9
Guangzhou 8
Jiaxing 8
Ningbo 8
Brooklyn 7
Chicago 7
Denver 7
Nanchang 7
Padova 7
Phoenix 7
Rome 7
Stockholm 6
Turku 6
Zhengzhou 6
Fairfield 5
Frankfurt am Main 5
Hangzhou 5
Johannesburg 5
San Francisco 5
Sindelfingen 5
Auburn Hills 4
Catanzaro 4
Changsha 4
Genova 4
Kochi 4
Lancaster 4
Montreal 4
Norwalk 4
Querétaro 4
Rio de Janeiro 4
San Jose 4
Seoul 4
Shanghai 4
Tokyo 4
Warsaw 4
Cabo Frio 3
Campinas 3
Chennai 3
Conselheiro Lafaiete 3
Detroit 3
Florence 3
Fuzhou 3
Governador Valadares 3
Haikou 3
Hải Dương 3
Kent 3
London 3
Novokuznetsk 3
Quito 3
Redwood City 3
Secaucus 3
Taiyuan 3
Tel Aviv 3
Atlanta 2
Baku 2
Bishkek 2
Biên Hòa 2
Totale 2.793
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 233
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 223
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 186
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 167
mTOR inhibitors and renal allograft: Yin and Yang. 164
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 164
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 159
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 158
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 156
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 155
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 151
Sulodexide and glycosaminoglycans in the progression of renal disease. 146
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 143
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 143
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 138
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 131
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 131
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 129
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 129
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 128
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 126
Heparanase as a target in cancer therapy. 125
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 124
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 122
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 121
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 119
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 117
Heparanase: another renal player controlled by vitamin d. 116
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 107
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 105
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 98
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 94
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 89
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 86
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 76
Impact of heparanase on renal fibrosis. 76
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 53
Totale 4.888
Categoria #
all - tutte 16.416
article - articoli 15.781
book - libri 0
conference - conferenze 635
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 26 11 9 5 3 33 45
2021/2022280 26 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025740 45 43 30 131 33 30 47 35 118 30 67 131
2025/20261.489 162 95 110 372 619 131 0 0 0 0 0 0
Totale 4.888